Teladoc Health Inc.
TDOC | NYSE
$6.26
-$0.01 (-0.16%)
Sep 22, 2026, 12:46 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -6.14 | -1.55 | -15.85 | -0.28 | -33.63 | -37.31 |
PEG Ratio | 0.08 | 0 | 0.16 | 0 | 0.69 | -0.13 |
PS Ratio | 0.49 | 0.60 | 1.34 | 1.59 | 7.09 | 16.54 |
PB Ratio | 0.89 | 1.04 | 1.50 | 1.65 | 0.90 | 1.14 |
P/FCF Ratio | 4.32 | 5.48 | 18.04 | 22.10 | 77.70 | -227.50 |
P/OCF Ratio | 4.19 | 5.28 | 9.98 | 20.17 | 74.28 | -338.22 |
OCF/S Ratio | 11.63 | 11.43 | 13.45 | 7.86 | 9.54 | -4.89 |
Debt / Equity Ratio | 0.75 | 1.06 | 0.68 | 0.69 | 0.08 | 0.09 |
Quick Ratio | 2.59 | 1.73 | 3.47 | 3.07 | 3.48 | 3.02 |
Current Ratio | 2.69 | 1.77 | 3.54 | 3.22 | 3.70 | 3.19 |
Asset Turnover | 0.82 | 0.73 | 0.59 | 0.51 | 0.11 | 0.06 |
Interest Coverage | -13.34 | -42.89 | -11.15 | -622.18 | -3.27 | -8.45 |
Return on Equity | -14.46% | -67.15% | -9.47% | -591.90% | -2.67% | -3.05% |
Return on Assets | -6.46% | -28.47% | -5.02% | -290.57% | -2.42% | -2.73% |
Return on Invested Capital | -8.26% | -32.55% | -6.24% | -316.34% | -1.53% | -2.44% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 69.50% | 70.76% | 70.80% | 69.09% | 68.01% | 64.27% |
Net Profit Margin | -7.92% | -38.97% | -8.47% | -567.53% | -21.09% | -44.35% |
Pretax Profit Margin | -9.31% | -38.67% | -8.44% | -567.69% | -18.92% | -52.65% |
Operating Profit Margin | -10.39% | -39.73% | -9.55% | -567.27% | -13.07% | -46.29% |
FCF Margin | 11.28% | 11.01% | 7.44% | 7.18% | 9.12% | -7.27% |
EBITDA Margin | 5.82% | 1.23% | 1.68% | -0.31% | -1.55% | -32.40% |
Add to Watchlist
Select watchlists to add or remove TDOC